Search    ENTER KEYWORD
MSDS Material Safety Data Sheet
CAS

10025-75-9

File Name: 10025-75-9.asp

                                          MATERIAL SAFETY DATA SHEET



I PRODUCT IDENTIFICATION

Trade Name: Erbium Chloride Chemical Formula: ErCl3 . nH20
Synonyms: Erbium Chloride Hexahydrate, Erbium Trichloride CAS #: 10025-75-9


II HAZARDOUS INGREDIENTS

Ingredient (s): Erbium Chloride (3+)
OSHA Hazardous(H)/Non-Hazardous (NH): H Percent: >99%

Sara Title III Hazard Classification: Immediate (Acute) Health Hazard.
WARNING STATEMENTS: SEVERE EYE IRRITANT.


III PHYSICAL DATA

Boiling Point oF: Decomposes Specific Gravity: Not available
Melting Point: Progressive dehydration starting at 212. Solubility in H2O: Soluble
Appearance and Odor: Pink crystalline solid/odorless % Volatile by volume: Not available
Vapor Pressure: 17.5 (for water component) pH: 4.5 to 5.8 (aqueous)


IV FIRE AND EXPLOSION HAZARDS DATA

Flash Point (Method used): Not applicable Flammable Limits: LFL: N/A UFL: N/A

Extinguishing Media: Water fog, Dry chemical, Foam, CO2.
Other: Use extinguishing media appropriate to surrounding fire conditions.

Special Fire Fighting Procedures: Wear a NIOSH/MSHA approved self-contained breathing apparatus and full protective clothing.
Cool containers exposed to fire with water.

Unusual Fire and Explosion Hazards: Under fire conditions and at high temperatures, highly toxic fumes of hydrogen chloride gas
emitted.


V HEALTH HAZARD INFORMATION

Exposure Limits in Air: (TLV or suggested control figure):

Chemical Name(s): ACGIH (TLV): OSHA (PEL):
10 mg/m3 15 mg/m3
Particulates
Not otherwise (TWA) total dust
5 mg/m3 respirable
Regulated total dust

Effects of Single Overexposure:
Swallowing: Studies performed on mice have shown rare earth chlorides to have low toxicity. Hydrates of rare earth chlorides are
not tolerated as well after ingestion. LD50 (mouse) anhydrous: 4417 (mg/kg)

Skin Absorption: No data found
Inhalation: No data found for rare earth chlorides. Good industrial hygiene practice recommends limiting exposure to all respirable
particulates.
Skin Contact: SEVERE IRRITANT ON ABRADED SKIN. Studies on this and other rare earth chlorides have shown these materi-
als to be non-irritating to intact skin but extremely irritating to abraded skin.
Eye Contact: SEVERE EYE IRRITANT. Studies on this and other rare earth chlorides have shown these materials to be very
irritating to the eye.

Effects of Repeated Overexposure: No toxic effects noted after chronic oral exposure in studies performed on animals.

Carcinogenicity: This product does not contain any ingredient designated by IARC, NTP, ACGIH, or OSHA as a probable human
carcinogen.

Significant Laboratory Data With Possible Relevance to Man: No additional data found.
Medical Conditions Possibly Aggravated by Overexposure: No additional data found.

EMERGENCY AND FIRST AID PROCEDURES:

EYES: In case of contact, immediately flush eyes with plenty of water for at least 15 minutes using an eyewash fountain. Lift upper
and lower lids and rinse well under them. Get immediate medical attention, preferably an eye specialist.
SKIN: In case of contact, immediately wash with soap and plenty of water for at least 5 minutes. Remove contaminated clothing and
shoes. Thoroughly clean contaminated clothing and shoes before reuse. Get medical attention if irritation develops or persists.
INHALATION: Remove from area of exposure. If not breathing, give artificial respiration. If breathing is difficult, give oxygen.
GET IMMEDIATE MEDICAL ATTENTION.
INGESTION: If swallowed and victim is fully conscious, induce vomiting immediately by giving two glasses of water and sticking
finger down throat. Get medical attention.

NOTE TO PHYSICIAN: All treatments should be based on observed signs and symptoms of distress in the patient. Consideration
should be given to the possibility that overexposure to materials other than this product may have occurred. Treat symptomatically.
No specific information found.


VI REACTIVITY DATA

Stability: Stable
Conditions to Avoid: Dusting conditions

Incompatibility (materials to avoid): Strong acids, strong oxidizing materials, strong bases.
Hazardous Decomposition Products or Byproducts: Toxic fumes of hydrogen chloride gas are released at decomposition tempera-
tures.

Hazardous Polymerization: Will not occur


VII SPILL OR LEAK PROCEDURES

Steps to be Taken in Case Material is Released or Spilled: Wear appropriate protective gear. Sweep up into appropriate container
for disposal or recovery. Avoid creating dusting conditions. Ventilate area. Neutralize spill area with calcium carbonate hydroxide
solution.

Waste Disposal Method: Dispose of in accordance with Local, State and Federal regulations.
VIII SPECIAL PROTECTION INFORMATION

Respiratory Protection: Under conditions requiring respiratory protection use a NIOSH/MSHA approved air purifying respirator
with particulate filter.

Ventilation: Provide adequate ventilation. Use local exhaust as needed.
Protective Clothing: Work uniform and gloves.

Eye Protection: Chemical Workers goggles.
Other: DO NOT WEAR CONTACT LENSES.

Other Protective Equipment: Maintain a sink, safety shower and eyewash fountain in the work area. Have oxygen readily avail-
able.


IX SPECIAL PRECAUTIONS

Other Handling and Storage Conditions: SEVERE EYE IRRITANT. SEVERE IRRITANT TO ABRADED SKIN. HYGRO-
SCOPIC. Store in tightly closed containers in cool dry place. Avoid breathing dusts. Avoid all direct contact with skin and eyes.
Change contaminated clothing promptly and launder before reuse. Wash hands thoroughly after handling. Do not rub eyes with
soiled hands. Do not eat, drink or smoke in the work area.

Other Precautions: Dry powders can build static electricity charges when subjected to the friction of conveying, mixing or sliding.
To prevent ignition, provide adequate precautions, such as electrical grounding, or inert atmospheres when material is used in the
presence of flammable materials.

Regulatory Status: TSCA Inventory Status: Product is TSCA certified. Listed under CAS #: 10138-41-7 for anhydrous erbium
chloride.

Transportation Status: Not regulated.
Reportable Quantity (RQ), under U.S. EPA CERCLA: None listed.

Specifically Listed under SARA Title III: Not listed.


Prepared by: S. Dierks
Dated: January 1995

ALL Chemical Analysis PAGES IN THIS GROUP
NAMECAS
7681-65-4.asp 7681-65-4 7553-56-2
1308-80-1.asp 1308-80-1
1317-38-0.asp 1317-38-0
20405-64-5.asp 20405-64-5
7440-50-8.asp 7440-50-8
1317-40-4.asp 1317-40-4
12019-52-2.asp 12019-52-2
12019-23-7.asp 12019-23-7
9002-84-0.asp 9002-84-0
espimetals_com_diammineplatinumnitride.asp N/A
espimetals_com_dysprosiumchloride.asp N/A
13569-80-7.asp 13569-80-7
espimetals_com_dysprosiumoxide.asp N/A
10025-75-9.asp 10025-75-9
13760-83-3.asp 13760-83-3
12159-66-9.asp 12159-66-9
13765-25-8.asp 13765-25-8
12008-06-9.asp 12008-06-9
10138-52-0.asp 10138-52-0
13765-26-9.asp 13765-26-9
10168-81-7.asp 10168-81-7 7697-37-2
25764-15-2.asp 25764-15-2
13450-88-9.asp 13450-88-9
13450-90-3.asp 13450-90-3
13450-91-4.asp 13450-91-4
13494-90-1.asp 13494-90-1
espimetals_com_galliumnitride.asp N/A
12024-21-4.asp 12024-21-4
12063-98-8.asp 12063-98-8
14024-24-7.asp 14024-24-7
12024-27-0.asp 12024-27-0
12024-14-5.asp 12024-14-5
7783-51-9.asp 7783-51-9
espimetals_com_goldacetate.asp N/A
866-84-2.asp 866-84-2 77-92-2
554-07-4.asp 554-07-4
13499-05-3.asp 13499-05-3
12656-74-5.asp 12656-74-5 11105-16-1
12055-23-1.asp 12055-23-1
13759-17-6.asp 13759-17-6
espimetals_com_hexachloroplatinicacid.asp N/A
13825-76-8.asp 13825-76-8
14483-18-2.asp 14483-18-2 7697-37-2
12055-62-8.asp 12055-62-8
1312-41-0.asp 1312-41-0
10025-82-8.asp 10025-82-8
espimetals_com_indiumnitrate.asp N/A
25617-98-5.asp 25617-98-5
1312-43-2.asp 1312-43-2
espimetals_com_indiumphosphide.asp N/A


HBCChem,Inc

Chemical Information Net chemcas.orgCopyright Reserved

Trading Lead

Leputech HPLC Laboratory